The tumor-promoting effect of PARP7 knockdown is also observed in the breast cancer xenografts and lower PARP7 expression is significantly correlated with poor prognosis of patients with breast cancer (Zhang L. et al., 2020). Here, TIPARP is linked to breast carcinoma.